Literature DB >> 12491830

[Prevalence of sexual dysfunction in climacteric women. Influence of menopause and hormone replace therapy].

Juan Enrique Blümel1, Hernán Araya, Ruth Riquelme, Gabriel Castro, Fabio Sánchez, Gloria Gramegna.   

Abstract

BACKGROUND: Few trials have studied the prevalence of sexual dysfunction (SD) and related risk factors in postmenopausal women using the DSM-IV criteria. AIM: To evaluate the prevalence of SD in menopausal women and the impact of risk factors. PATIENTS AND METHODS: Five hundred thirty four healthy women, 40 to 64 years of age were interviewed using the Laumann test (DSM-IV).
RESULTS: Mean age was 52.4 +/- 5.7 years. Eighty three percent were peri or postmenopausal, 23% used hormonal substitution therapy and 79.2% were sexually active. Among sexually active women, the prevalence of SD increased along with age, from 22.2% at the 40-44 years old range to 66.0% in the 60-64 years old group. Hormone users and healthy women had a low risk for SD (Odds ratio (OR): 0.1 IC: 0.0-0.1 and OR: 0.6 IC: 0.3-0.9, respectively). The risk increased in menopausal women (OR: 3.3 IC: 1.6-6.9), those older than 49 years (OR: 3.4 IC: 1.8-6.4), those subjected to hysterectomy (OR: 3.7 IC: 1.3-10.6) or those with an impotent sexual partner (OR: 3.2 IC: 1.2-8.6).
CONCLUSIONS: There is a high prevalence of SD among climacteric women. Estrogens, either endogenous or exogenous, have a positive influence on sexuality.

Entities:  

Mesh:

Year:  2002        PMID: 12491830

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  4 in total

1.  Dyspareunia is associated with decreased frequency of intercourse in the menopausal transition.

Authors:  Holly M Thomas; Cindy L Bryce; Roberta B Ness; Rachel Hess
Journal:  Menopause       Date:  2011-02       Impact factor: 2.953

2.  Night sweats, sleep disturbance, and depression associated with diminished libido in late menopausal transition and early postmenopause: baseline data from the Herbal Alternatives for Menopause Trial (HALT).

Authors:  Susan D Reed; Katherine M Newton; Andrea Z LaCroix; Lou C Grothaus; Kelly Ehrlich
Journal:  Am J Obstet Gynecol       Date:  2007-06       Impact factor: 8.661

3.  Severity of climacteric symptomatology related to depression and sexual function in women from a private clinic.

Authors:  Alexandra Lińan-Bermudez; Jhony Chafloque-Chavesta; Pamela Leon Pastuso; Kiaraliz Huambachano Pinedo; John Barja-Ore
Journal:  Prz Menopauzalny       Date:  2022-09-28

4.  Sexual dysfunction prevalence in a group of pre- and postmenopausal Mexican women.

Authors:  Sebastián Carranza-Lira; Flor de Durazno Casillas Núñez
Journal:  Prz Menopauzalny       Date:  2018-04-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.